RVNC Revance Therapeutics6.96+1.30 (+23.0%)
After Hours Gainer
RVNC Revance Therapeutics5.66-0.04-0.7%
After Hours:6.09+0.43 (+7.6%)
Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update
Business WireWed, 28-Feb 4:05 PM
RVNC Revance Therapeutics5.61-0.09 (-1.6%)
RVNC Revance Therapeutics6.78-1.57 (-18.8%)
RVNC Revance Therapeutics8.76-0.55 (-5.9%)